Biohm Technologies, a leader in microbiome research and product innovation, announced today that Mycohsa™, the company’s clinically supported probiotic blend, has received a Natural Product Number (NPN) from Health Canada.
The approval applies to Mycohsa™ 1 billion CFU capsules (NPN/PLA Number 80148767) and allows dietary supplement brands marketing products in Canada to formulate with Mycohsa™ under an approved framework that includes a range of permitted probiotic structure/function claims related to digestive and gastrointestinal health.
Health Canada’s NPN system is widely recognized within the supplement industry as an important regulatory pathway for natural health products sold in Canada. Companies formulating with ingredients that already hold an NPN can often streamline product development and registration efforts for the Canadian market.
Mycohsa™ is Biohm Technologies’ flagship probiotic blend, developed with a multi-kingdom approach that combines beneficial bacterial and fungal strains. The ingredient was designed to support digestive health and help maintain a healthy gut microbiome balance.
“This approval represents an important milestone for Mycohsa™ and for our partners in the Canadian market,” said Kristin Wilhoyte, VP of Marketing at Biohm Technologies. “Having an approved NPN gives brands additional confidence and flexibility when developing products for Canada.”